{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:18Z","timestamp":1787020698600,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>North America remains in the midst of an escalating opioid overdose epidemic, largely driven by the influx of synthetic opioids such a fentanyl and related analogues. High rates of mental illness among substance-using populations have been well documented; in particular, opioid-using individuals suffer from high rates of PTSD. Despite the devastating disease burden of both PTSD and OUD, especially within the context of the current opioid overdose epidemic, treatment options and outcomes remain suboptimal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Comorbid PTSD-OUD is often complex and inextricably intertwined, thereby impeding effective diagnosis, assessment and early intervention. Best outcomes occur when treatment addresses both comorbidities simultaneously, known as parallel or integrative approaches. Despite these findings, affected individuals often do not receive adequate or equitable access to healthcare. The WHO recommends that public spending for both mental and physical aspects of healthcare be equitable to the burden of disease. Despite these recommendations mental healthcare services remain chronically underfunded in Canada. The Mental Health Parity Act is a call for the Canadian government to implement equitable public spending on all aspects of healthcare. Furthermore, prohibitory legislative practices serve to marginalize substance-using populations thereby increasing the likelihood of exposure to traumatic violence and other associated harms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Efforts are now needed to address regulatory drug-use frameworks and public healthcare policies that perpetuate these inequalities. Alternative regulatory frameworks for drugs and mental health parity should be implemented and evaluated in an effort to reduce violence, trauma and ultimately opioid-related overdose deaths.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-020-00264-8","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T09:07:07Z","timestamp":1584349627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["PTSD and opioid use: implications for intervention and policy"],"prefix":"10.1186","volume":"15","author":[{"given":"Lucia","family":"Dahlby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"264_CR1","unstructured":"Public Health Agency of Canada. National report: apparent opioid-related deaths in Canada (released April 2019). Canada.ca. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/national-report-apparent-opioid-related-deaths-released-september-2018.Html. Published April 10, 2019. Accessed 24 May 2019."},{"key":"264_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cpr.2015.02.007","volume":"38","author":"NP Roberts","year":"2015","unstructured":"Roberts NP, Roberts PA, Jones N, Bisson JI. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2015;38:25\u201338.","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"264_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/10550887.2013.795467","volume":"32","author":"A Fareed","year":"2013","unstructured":"Fareed A, Eilender P, Haber M, Bremner J, Whitfield N, Drexler K. Comorbid posttraumatic stress disorder and opiate addiction: a literature review. J Addict Dis. 2013;32(2):168\u201379.","journal-title":"J Addict Dis"},{"issue":"6","key":"264_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1037\/tra0000312","volume":"10","author":"AH Ecker","year":"2018","unstructured":"Ecker AH, Hundt N. Posttraumatic stress disorder in opioid agonist therapy: A review. Psychol Trauma. 2018;10(6):636.","journal-title":"Psychol Trauma"},{"issue":"1","key":"264_CR5","doi-asserted-by":"publisher","first-page":"17734","DOI":"10.3402\/ejpt.v3i0.17734","volume":"3","author":"N Gielen","year":"2012","unstructured":"Gielen N, Havermans R, Tekelenburg M, Jansen A. Prevalence of post-traumatic stress disorder among patients with substance use disorder: it is higher than clinicians think it is. Eur J Psychotraumatol. 2012;3(1):17734.","journal-title":"Eur J Psychotraumatol"},{"issue":"5","key":"264_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","volume":"103","author":"RP Schwartz","year":"2013","unstructured":"Schwartz RP, Gryczynski J, O\u2019grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009. Am J Public Health. 2013;103(5):917\u201322.","journal-title":"Am J Public Health"},{"key":"264_CR7","unstructured":"Abuse S, (US), Mental Health Services Administration, (US), Office of the Surgeon General, NCBI Bookshelf. Facing Addiction in America: The Surgeon General\u2019s Report on Alcohol, Drugs and Health. US Department of Health and Human Services; 2016."},{"key":"264_CR8","unstructured":"Mental health in the balance: ending the health care disparity in Canada. In: Public policy. Canadian Mental Health Association. 2018. https:\/\/cmha.ca\/wp-content\/uploads\/2018\/09\/CMHA-Parity-Paper-Full-Report-EN.pdf. Accessed 24 May 2019."},{"issue":"2","key":"264_CR9","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/S2468-2667(18)30203-2","volume":"4","author":"DV Vigo","year":"2019","unstructured":"Vigo DV, Kestel D, Pendakur K, Thornicroft G, Atun R. Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas. Lancet Public Health. 2019;4(2):e89\u201396.","journal-title":"Lancet Public Health"},{"issue":"6","key":"264_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/bjc\/azq038","volume":"50","author":"CE Hughes","year":"2010","unstructured":"Hughes CE, Stevens A. What can we learn from the Portuguese decriminalization of illicit drugs? Bri J Criminol. 2010;50(6):999\u20131022.","journal-title":"Bri J Criminol"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-020-00264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-020-00264-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-020-00264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T21:01:56Z","timestamp":1615842116000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-020-00264-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1186\/s13011-020-00264-8","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}